The Vanguard Group 13D and 13G filings for Seelos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:32 am Sale |
2022-12-30 | 13G | Seelos Therapeutics, Inc. SEEL |
The Vanguard Group | 1,306 4.680% |
-34 (-2.52%) |
Filing |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
The Vanguard Group | 1,340 5.030% |
611 (+83.81%) |
Filing |
| 2021-02-10 11:52 am Purchase |
2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
The Vanguard Group | 729 5.240% |
729 (New Position) |
Filing |